Neurocutaneous Flashcards

1
Q

What is the de novo rate of NF1?

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the seven criteria for NF1?

A

2 or more of the following criteria:

  1. > = 6 cafe-au-lait spots (>5mm prepubertal; >15mm post-pubertal)
  2. > = 2 neurofibromas of any type; >= 1 plexiform neurofibroma
  3. > = 2 Lisch nodules
  4. Freckling in axilla or groin
  5. Optic glioma
  6. First degree relative with NF1
  7. Distinctive bony lesion (dysphagia of the sphenoid bone, dysphagia or thinning of long bone cortex)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the nervous system manifestations in NF1?

A
  • Macrocephaly (30-45%)
  • Learning disability (30-65%)
  • MRI ‘brightspots’ on T2 (UBO
  • Headache (9-10%)
    *Epilepsy (3.5-7%)
    *Cerebrovascular dysplasia (2-6%, e.g. Moya Moya)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the tumors seen in NF1?

A

PNS:
Plexiform neurofibroma
Malignant peripheral nerve sheath tumors (neurofibrosarcomas-10%)

CNS:
Pilocytic astrocytoma (20%)
Optic pathway and hypothalamic predominance (24%)
High grade gliomas in >6yr, or outside optic pathway

Non-CNS (acquired second hit):
Pheochromocytoma (0.1-5.7%)
GI stromal
Glomus tumors
Breast CA
Rhabdomyosarcomas
NE-Carcinoid tumors
Juvenile myelocytic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When is the risk for growth of neurofibromas in NF1?

A

Early childhood
Adolescence
Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the differential diagnosis for NF1?

A

Legius syndrome (SPRED1 mutations)
Homozygous for HNPCC mutations
NF2/schwannomatosis
Noonan syndrome/LEOPARD syndrome
McCune Albright syndrome
MEN2
Multiple lipomatosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the gene and phenotype for Legius syndrome?

A

SPRED1 (AD)

CALs, freckling, and macrocephaly
No neurofibromas, Lisch nodules, optic gliomas, osseous lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the NF1/Noonan phenotype?

A

Short stature
Webbed neck
Facial dysmorphism
Pulmonary stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the facial features of Noonan syndrome?

A

Epicanthal folds
Ptosis
Downslanting palpebral fissures (95%)
Triangular facies
High nasal bridge
Low-set, posterior rotated ears
Thickened pinnae/helix (90%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Selumetinib?

A

The drug used in inoperable plexiform neurofibromas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What criteria must be met for Neurofibromatosis type 2?

A

Must meet one of the following criteria:

  1. Bilateral vestibular schwannomas (VS)
  2. First-degree relative with NF2 AND unilateral VS
  3. First-degree relative with NF2 OR unilateral VS and two of:
    -Meningioma, cataract, glioma, neurofibroma
    -Schwannoma, cerebral calcification
  4. Multiple meningioma (2 or more) AND two of:
    -Unilateral VS, cataract, glioma, neurofibroma, schwannoma, cerebral calcification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What percentage of NF2 is de novo?

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What percentage of de novo NF2 mutations are mosaic?

A

25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the top 3 presenting symptoms in NF2?

A

Unilateral hearing loss (35%)
Focal weakness (12%)
Tinnitus (10%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the ocular findings in NF2?

A

Decreased visual acuity in 1/3 of pts.

Retinal hamartoma and epiretinal membrane

Posterior sub-capsular lens opacity

Corneal damage

Intra-orbital tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the lifetime risk of meningiomas in NF2?

A

75%

17
Q

What genes are the cause of SCHWANNOMATOSIS?

A

SMARCB1
LZTR1

18
Q

What is the phenotype of SCHWANNOMATOSIS?

A

Multiple schwannomas, without acoustic tumors
Intracranial, spinal nerve root, peripheral nerve tumors
Pain and neurological manifestations

19
Q

What percentage of SCHWANNOMATOSIS is familial?

A

10%

20
Q

What is the phenotype of Neurocutaneous Melanosis?

A

Abnormal pigmented nevi

Present at birth

Hydrocephalus
Recurrent seizures

CSF: High protein, Low glucose, melanocytes

Poor prognosis

21
Q

What is the genetic cause of Neurocutaneous Melanosis?

A

Most commonly results from an embryonic postzygotic somatic mutation in NRAS

22
Q

What percentage of TSC is de novo?

A

2/3

23
Q

What percentage of TSC is due to germline mosaicism?

A

~2%

24
Q

What percentage of TSC is due to mutations in TSC1? TSC2?

A

19%; 60%

25
Q

What are the brain findings in TSC?

A

Cortical tubers (>80%)
Subependymal nodule (~80%)
Subependymal astrocytoma

26
Q

What are the neurological manifestations in TSC?

A

Intractable seizures (90-96%), infantile spasms most common
Behavioral and cognitive dysfunction (40-50%)
Autism

27
Q

What are the major features of TSC?

A
  1. Hypomelanotic macules (>3, at least 5mm)
  2. Angiofibromas (>3) or fibrous cephalic plaque
  3. Ungual fibromas (>2)
  4. Shagreen patch
  5. Multiple retinal harmartomas
  6. Cortical dysplasias
  7. Subependymal nodules
  8. Subependymal giant cell astrocytoma
  9. Cardiac rhabdomyoma
  10. Lymphangioleiomyomatosis
  11. Angiomyolipomas (>2)
28
Q

What are the minor features of TSC?

A
  1. Confetti skin lessions
  2. Dental enamel pits (>3)
  3. Intraoral fibromas (>2)
  4. Retinal achromic patch
  5. Multiple renal cysts
  6. Nonrenal hamartomas
29
Q

What is the phenotype of Sturge-Weber Syndrome?

A

Facial port wine stain in the V1 distribution of trigeminal nerve associated with leptomeningeal angiomatosis

Seizures (55-90%)
Glaucoma (60%)
DD (55%)

30
Q

How common is port wine stain in newborns

A

~0.3%

31
Q

What is the genetic cause of Sturge-Weber Syndrome?

A

Somatic mutations in GNAQ

32
Q

What is the phenotype of Osler-Weber-Rendu syndrome?

A

Hereditary hemorrhagic telangiectasia (AVMs-most common locations affected are the nose, lungs, brain and liver)

Recurrent nosebleeds

Skin changes begin at puberty

Disease progressively worsens

33
Q

What are the gene changes in Osler-Weber-Rendu syndrome?

A

ENG, ACVRL1, SMAD4, GDF2
(90% of cases)

34
Q

What is the phenotype of Von Hippel-Lindau syndrome?

A

Tumors and cysts to grow in certain parts of the body, including the brain, spinal cord, eyes, inner ear, adrenal glands, pancreas, kidney, and reproductive tract.

The tumors are usually benign (not cancer), but some may be malignant (cancer).

35
Q

What is the gene change in Von Hippel-Lindau syndrome?

A

AD mutations in VHL gene

36
Q

When do neurofibromas develop in NF1?

A

Preteen and adolescent years

37
Q

When do plexiform neurofibromas develop in NF1?

A

Congenital